ATM and related protein kinases: Safeguarding genome integrity

Nature Reviews Cancer

Volumn 3, Issue 3, 2003, Pages 155-168

  Shiloh, Yosef ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; DOUBLE STRANDED DNA; PROTEIN KINASE; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

ATAXIA TELANGIECTASIA; CANCER SUSCEPTIBILITY; DNA DAMAGE; DNA STRAND BREAKAGE; GENETIC STABILITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; CELL TRANSFORMATION; CHROMOSOME BREAKAGE; DNA REPAIR; ENZYME ACTIVATION; ENZYMOLOGY; FAMILIAL CANCER; GENE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MOUSE; MOUSE MUTANT; MULTIGENE FAMILY; PHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ATAXIA TELANGIECTASIA; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME BREAKAGE; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; ENZYME ACTIVATION; GENES, CDC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; MICE, KNOCKOUT; MODELS, GENETIC; MULTIGENE FAMILY; NEOPLASTIC SYNDROMES, HEREDITARY; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 0037365789     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1011     Document Type: Review

References (173)

1. Hahn, W. C. & Weinberg, R. A. Modelling the molecular circuitry of cancer. Nature Rev. Cancer 2, 331-341 (2002).
2. Levitt, N. C. & Hickson, I. D. Caretaker tumour suppressor genes that defend genome integrity. Trends Mol. Med. 8, 179-186 (2002).
3. Hoeijmakers, J. H. Genome maintenance mechanisms for preventing cancer. Nature 411, 366-374 (2001).
4. Davidson, J. F., Guo, H. H. & Loeb, L. A. Endogenous mutagenesis and cancer. Mutat. Res. 509, 17-21 (2002).
5. Vessey, C. J., Norbury, C. J. & Hickson, I. D. Genetic disorders associated with cancer predisposition and genomic instability. Prog. Nucleic Acid Res. Mol. Biol. 63, 189-221 (1999).
6. Moses, R. E. DNA damage processing defects and disease. Annu. Rev. Genom. Hum. Genet. 2, 41-68 (2001).
7. Thompson, L. H. & Schild, D. Recombinational DNA repair and human disease. Mutat. Res. 509, 49-78 (2002).
8. O'Driscoll, M. & Jeggo, P. Immunological disorders and DNA repair. Mutat. Res. 509, 109-126 (2002).
9. Rouse, J. & Jackson, S. P. Interfaces between the detection, signaling, and repair of DNA damage. Science 297, 547-551 (2002).
10. Jackson, S. P. Sensing and repairing DNA double-strand breaks Carcinogenesis 23, 687-696 (2002).
11. Khanna, K. K. & Jackson, S. P. DNA double-strand breaks: signaling, repair and the cancer connection. Nature Genet. 27, 247-254 (2001).
12. van Gent, D. C., Hoeijmakers, J. H. & Kanaar, R. Chromosomal stability and the DNA double-stranded break connection. Nature Rev. Genet. 2, 196-206 (2001).
13. Bartek, J. & Lukas, J. Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr. Opin. Cell. Biol. 13, 738-747 (2001).
14. Pearce, A. K. & Humphrey, T. C. Integrating stress-response and cell-cycle checkpoint pathways. Trends Cell Biol. 11, 426-433 (2001).
15. Amundson, S. A., Bittner, M., Meltzer, P., Trent, J. & Fornace, A. J., Jr. Induction of gene expression as a monitor of exposure to ionizing radiation. Radiat. Res. 156, 657-661 (2001).
16. Jelinsky, S. A., Estep, P., Church, G. M. & Samson, L. D. Regulatory networks revealed by transcriptional profiling of damaged Saccharomyces cerevisiae cells: Rpn4 links base excision repair with proteasomes. Mol. Cell. Biol. 20, 8157-8167 (2000).
17. Sesto, A., Navarro, M., Burslem, F. & Jorcano, J. L. Analysis of the ultraviolet B response in primary human keratinocytes using oligonucleotide microarrays. Proc. Natl Acad. Sci. USA 99, 2965-2970 (2002).
18. Shiloh, Y. ATM and ATR: networking cellular responses to DNA damage. Curr. Opin. Genet. Dev. 11, 71-77 (2001).
19. Shiloh, Y. & Kastan, M. B. ATM: genome stability, neuronal development, and cancer cross paths. Adv. Cancer Res. 83, 209-254 (2001).
20. Abraham, R. T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15, 2177-2196 (2001).
21. Durocher, D. & Jackson, S. P. DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme? Curr. Opin. Cell. Biol. 13, 225-231 (2001).
22. Khanna, K. K., Lavin, M. F., Jackson, S. P. & Mulhern, T. D. ATM, a central controller of cellular responses to DNA damage. Cell Death Differ. 8, 1052-1065 (2001).
23. McMahon, S. B., Wood, M. A. & Cole, M. D. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol. Cell. Biol. 20, 556-562 (2000).
24. Nikiforov, M. A. et al. TRRAP-dependent and TRRAP-independent transcriptional activation by Myc family oncoproteins. Mol. Cell. Biol. 22, 5054-5063 (2002).
25. Proud, C. G. Regulation of mammalian translation factors by nutrients. Eur. J. Biochem. 269, 5338-5349 (2002).
26. Dennis, P. B. & Thomas, G. Quick guide: target of rapamycin. Curr. Biol. 12, R269 (2002).
27. Savitsky, K. et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268, 1749-1753 (1995).
28. Crawford, T. O. Ataxia telangiectasia. Semin. Pediatr. Neurol. 5, 287-294 (1998).
29. Becker-Catania, S. G. & Gatti, R. A. Ataxia-telangiectasia. Adv. Exp. Med. Biol. 495, 191-198 (2001).
30. Kim, S. T., Lim, D. S., Canman, C. E. & Kastan, M. B. Substrate specificities and identification of putative substrates of ATM kinase family members. J. Biol. Chem. 274, 37538-37543 (1999).
31. O'Neill, T. et al. Utilization of oriented peptide libraries to identify substrate motifs selected by ATM. J. Biol. Chem. 275, 22719-22727 (2000).
32. Banin, S. et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281, 1674-1677 (1998). References 32, 33 and 37 provided the first complete description of an ATM target - Ser15 of p53. References 32 and 33 provided the first evidence for ATM activation following DNA damage.
33. Canman, C. E. et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677-1679 (1998).
34. Kozlov, S., Gueven, N., Keating, K., Ramsay, J. & Lavin, M. F. ATP activates ATM in vitro: importance of autophosphorylation. J. Biol. Chem. (in the press).
35. Bakkenist, C. J. & Kastan, M. B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421, 499-506 (2003). This seminal work solved the basic mechanism of ATM activation: ATM lies dormant as dimers in undamaged cells, with its kinase domain being blocked by this interaction. Rapid intermolecular phosphorylation that follows DSB induction immediately releases very active ATM monomers.
36. Andegeko, Y. et al. Nuclear retention of ATM at sites of DNA double strand breaks. J. Biol. Chem. 276, 38224-38230 (2001). This work described the tight adherence of ATM to the damaged sites in the DNA following DSB induction: a fraction of ATM seems to be allocated to duties to be carried out at the site of the damage.
37. Khanna, K. K. et al. ATM associates with and phosphorylates p53: mapping the region of interaction. Nature Genet. 20, 398-400 (1998).
38. Khosravi, R. et al. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc. Natl Acad. Sci. USA 96, 14973-14977 (1999).
39. Ashcroft, M., Kubbutat, M. H. & Vousden, K. H. Regulation of p53 function and stability by phosphorylation. Mol. Cell. Biol. 19, 1751-1758 (1999).
40. Dumaz, N. & Meek, D. W. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J. 18, 7002-7010 (1999).
41. McGowan, C. H. Checking in on Cds1 (Chk2): a checkpoint kinase and tumor suppressor. Bioessays 24, 502-511 (2002).
42. Bartek, J., Falck, J. & Lukas, J. CHK2 kinase: a busy messenger. Nature Rev. Mol. Cell. Biol. 2, 877-886 (2001).
43. Ryan, K. M., Phillips, A. C. & Vousden, K. H. Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell. Biol. 13, 332-337 (2001).
44. Oren, M. et al. Regulation of p53: intricate loops and delicate balances Biochem. Pharmacol. 64, 865-871 (2002).
45. Maya, R. et al. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 15, 1067-1077 (2001).
46. Saito, S. et al. ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation. J. Biol. Chem. 277, 12491-12494 (2002).
47. Waterman, M. J., Stavridi, E. S., Waterman, J. L. & Halazonetis, T. D. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nature Genet. 19, 175-178 (1998).
48. Wang, Y. et al. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14, 927-939 (2000).
49. Venkitaraman, A. R. Cancer susceptibility and the functions of BRCA1 and BRCA2 Cell 108, 171-182 (2002).
50. Jasin, M. Homologous repair of DNA damage and tumorigenesis: the BRCA connection. Oncogene 21, 8981-8993 (2002).
51. Yarden, R. I., Pardo-Reoyo, S., Sgagias, M., Cowan, K. H. & Brody, L. C. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nature Genet. 30, 285-289 (2002).
52. El-Deiry, W. S. Transactivation of repair genes by BRCA1. Cancer Biol. Ther. 1, 490-491 (2002).
53. Cortez, D., Wang, Y., Qin, J. & Elledge, S. J. Requirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks. Science 286, 1162-1166 (1999). ATM-mediated phosphorylation of BRCA1 was demonstrated in references 53-55, connecting two cancer-predisposing genes in the web of the DNA-damage response.
54. Gatei, M. et al. Role for ATM in DNA damage-induced phosphorylation of BRCA1. Cancer Res. 60, 3299-3304 (2000).
55. Gatei, M. et al. Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies. J. Biol. Chem. 216, 17276-17280 (2001).
56. Xu, B., O'Donnell, A. H., Kim, S. T. & Kastan, M. B. Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation. Cancer Res. 62, 4588-4591 (2002). Work described in references 56 and 57 showed how ATM-mediated phosphorylation of BRCA1 on different sites directs it to act at different cell-cycle checkpoints. These results show the finesse of ATM's control of downstream pathways.
57. Xu, B., Kim, S. & Kastan, M. B. Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol. Cell. Biol. 21, 3445-3450 (2001).
58. Lee, J. S., Collins, K. M., Brown, A. L., Lee, C. H. & Chung, J. H. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 404, 201-204 (2000).
59. Li, S. et al. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature 406, 210-215 (2000).
60. Lim, D. S. et al. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 404, 613-617 (2000). Experiments in references 60-63 show ATM-mediated phosphorylation of the NBS1 protein and provided the first functional explanation of the partial overlap between A-T and NBS1, two chromosomal instability syndromes.
61. Zhao, S. et al. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature 405, 473-477 (2000).
62. Gatei, M. et al. ATM-dependent phosphorylation of nibrin in response to radiation exposure. Nature Genet. 25, 115-119 (2000).
63. Wu, X. et al. ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature 405, 477-482 (2000).
64. D'Amours, D. & Jackson, S. P. The MRE11 complex: at the crossroads of DNA repair and checkpoint signalling. Nature Rev. Mol. Cell. Biol. 3, 317-327 (2002).
65. Kim, S. T., Xu, B. & Kastan, M. B. Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage. Genes Dev. 16, 560-570 (2002).
66. Yazdi, P. T. et al. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev. 16, 571-582 (2002).
67. Taniguchi, T. et al. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. Cell 109, 459-472 (2002). Here, an important functional link between two apparently remote chromosomal instability syndromes was firmly established by showing ATM-mediated phosphorylation of one of the Fanconi's anaemia proteins following DNA damage.
68. Mailand, N. et al. Rapid destruction of human Cdc25A in response to DNA damage. Science 288, 1425-1429 (2000).
69. Falck, J., Mailand, N., Syljuasen, R. G., Bartek, J. & Lukas, J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410, 842-847 (2001).
70. Falck, J., Petrini, J. H., Williams, B. R., Lukas, J. & Bartek, J. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nature Genet. 30, 290-294 (2002). This work revealed two distinct mechanisms by which the important intra-S cell-cycle checkpoint is fine-tuned.
71. Mailand, N. et al. Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO J. 21, 5911-5920 (2002).
72. Zhao, H., Watkins, J. L. & Piwnica-Worms, H. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc. Natl Acad. Sci. USA 99, 14795-14800 (2002).
73. Bell, D. W. et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286, 2528-2531 (1999).
74. Sodha, N. et al. Increasing evidence that germline mutations in CHEK2 do not cause Li-Fraumeni syndrome. Hum. Mutat. 20, 460-462 (2002).
75. Meijers-Heijboer, H. et al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nature Genet. 31, 55-59 (2002).
76. Vahteristo, P. et al. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am. J. Hum. Genet. 71, 432-438 (2002).
77. Bao, S. et al. ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses. Nature 411, 969-974 (2001).
78. Post, S. et al. Phosphorylation of serines 635 and 645 of human Rad17 is cell cycle regulated and is required for G(1)/S checkpoint activation in response to DNA damage. Proc. Natl Acad. Sci. USA 98, 13102-13107 (2001).
79. Thelen, M. P., Venclovas, C. & Fidelis, K. A sliding clamp model for the Rad1 family of cell cycle checkpoint proteins. Cell 96, 769-770 (1999).
80. Venclovas, C. & Thelen, M. P. Structure-based predictions of Rad1, Rad9, Hus1 and Rad17 participation in sliding clamp and clamp-loading complexes. Nucleic Acids Res. 28, 2481-2493 (2000).
81. Rauen, M., Burtelow, M. A., Dufault, V. M. & Karnitz, L. M. The human checkpoint protein hRad17 interacts with the PCNA-like proteins hRad1, hHus1, and hRad9. J. Biol. Chem. 275, 29767-29771 (2000).
82. Roos-Mattjus, P. et al. Genotoxin-induced Radg-Hus1-Rad1 (9-1-1) chromatin association is an early checkpoint signaling event. J. Biol. Chem. 277, 43809-43812 (2002).
83. Chen, M. J., Lin, Y. T., Lieberman, H. B., Chen, G. & Lee, E. Y. ATM-dependent phosphorylation of human Rad9 is required for ionizing radiation-induced checkpoint activation. J. Biol. Chem. 276, 16580-16586 (2001).
84. Redon, C. et al. Histone H2A variants H2AX and H2AZ. Curr. Opin. Genet. Dev. 12, 162-169 (2002).
85. Celeste, A. et al. Genomic instability in mice lacking histone H2AX. Science 296, 922-927 (2002).
86. Burma, S., Chen, B. P., Murphy, M., Kurimasa, A. & Chen, D. J. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 276, 42462-42467 (2001).
87. Ward, I. M. & Chen, J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem. 276, 47759-47762 (2001).
88. Buscemi, G. et al. Chk2 activation dependence on Nbs1 after DNA damage. Mol. Cell. Biol. 21, 5214-5222 (2001).
89. Girard, P. M., Riballo, E., Begg, A. C., Waugh, A. & Jeggo, P. A. Nbs1 promotes ATM dependent phosphorylation events including those required for G1/S arrest. Oncogene 21, 4191-4199 (2002).
90. DiTullio, R. A. Jr et al. 53BP 1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nature Cell Biol. 4, 998-1002 (2002).
91. Fernandez-Capetillo, O. et al. DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nature Cell Biol. 4, 993-997 (2002).
92. Wang, B., Matsuoka, S., Carpenter, P. B. & Elledge, S. J. 53BP1, a mediator of the DNA damage checkpoint. Science 298, 1435-1438 (2002).
93. Peng, A. & Chen, P. L. NFBD1, like 53BP1, is an early and redundant transducer mediating Chk2 phosphorylation in response to DNA damage. J. Biol. Chem. 24 Jan 2003 [epub ahead of print].
94. Shang, Y. L., Bodero, A. J. & Chen, P. L. NFBD1, a novel nuclear protein with signature motifs of FHA and BRCT, and an internal 41 amino acid repeat sequence, is an early participant in DNA damage response. J. Biol. Chem. 9 Dec 2002 [epub ahead of print].
95. Xu, X. & Stern, D. F. NFBD1/KIAA0170 is a chromatin-associated protein involved in DNA damage signaling pathways. J. Biol. Chem. 23 Dec 2002 [epub ahead of print].
96. Chen, G. et al. Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J. Biol. Chem. 274, 12748-12752 (1999).
97. Morrison, C. et al. The controlling role of ATM in homologous recombinational repair of DNA damage. EMBO J. 19, 463-471 (2000).
98. Yuan, Z. M. et al. Regulation of Rad51 function by c-Abl in response to DNA damage. J. Biol. Chem. 273, 3799-3802 (1998).
99. Kitao, H. & Yuan, Z. M. Regulation of ionizing radiation-induced Rad52 nuclear foci formation by c-Abl-mediated phosphorylation. J. Biol. Chem. 277, 48944-48948 (2002).
100. Shafman, T. et al. Interaction between ATM protein and c-Abl in response to DNA damage. Nature 387, 520-523 (1997).
101. Baskaran, R. et al. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387, 516-519 (1997).
102. Shangary, S. et al. Regulation of DNA-dependent protein kinase activity by ionizing radiation-activated abl kinase is an ATM-dependent process. J. Biol. Chem. 275, 30163-30168 (2000).
103. Foray, N. et al. Constitutive association of BRCA1 and c-Abl and its ATM-dependent disruption after irradiation. Mol. Cell. Biol. 22, 4020-4032 (2002).
104. Lin, W. C., Lin, F. T. & Nevins, J. R. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 15, 1833-1844 (2001).
105. Bar-Shira, A. et al. ATM-dependent activation of the gene encoding MAP kinase phosphatase 5 by radiomimetic DNA damage. Oncogene 21, 849-855 (2002).
106. Wang, X. et al. Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol. Cell. Biol. 20, 4543-4552 (2000).
107. Li, N. et al. ATM is required for IkappaB kinase (IKKk) activation in response to DNA double strand breaks. J. Biol. Chem. 276, 8898-3903 (2001).
108. Pandita, T. K. The role of ATM in telomere structure and function. Radiat. Res. 156, 642-647 (2001).
109. Maser, R. S. & DePinho, R. A. Connecting chromosomes, crisis, and cancer. Science 297, 565-569 (2002).
110. Kim, S. H., Kaminker, P. & Campisi, J. Telomeres, aging and cancer: in search of a happy ending. Oncogene 21, 503-511 (2002).
111. Chan, S. W. & Blackburn, E. H. New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin. Oncogene 21, 553-563 (2002).
112. Karlseder, J., Broccoli, D., Dai, Y., Hardy, S. & de Lange, T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283, 1321-1325 (1999).
113. Wong, K. K. et al. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 22 Jan 2003 [epub ahead of print]. Mice doubly deficient for Atm and the telomerase RNA component showed a marked proliferative defect, genome stability and premature ageing, pointing at the importance of the defect in telomere maintenance in some A-T symptoms.
114. Kishi, S. et al. Telomeric protein Pin2/TRF1 as an important ATM target in response to double strand DNA breaks. J. Biol. Chem. 276, 29282-29291 (2001).
115. Kishi, S. & Lu, K. P. A critical role for Pin2/TRF1 in ATM-dependent regulation. Inhibition of Pin2/TRF1 function complements telomere shortening, radiosensitivity, and the G(2)/M checkpoint defect of ataxia-telangiectasia cells. J. Biol. Chem. 277, 7420-7429 (2002).
116. Perkins, E. J. et al. Sensing of intermediates in V(D)J recombination by ATM. Genes Dev. 16, 159-164 (2002).
117. Xu, Y. ATM in lymphoid development and tumorigenesis. Adv. Immunol. 72, 179-189 (1999).
118. Tauchi, H., Matsuura, S., Kobayashi, J., Sakamoto, S. & Komatsu, K. Nijmegen breakage syndrome gene, NBS1, and molecular links to factors for genome stability. Oncogene 21, 8967-8980 (2002).
119. Stewart, G. S. et al. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99, 577-587 (1999). Here, the molecular basis for A-T-like disease (ATLD) - MRE11 deficiency - was identified. This discovery and the striking clinical similarity between A-T and ATLD point to intimate functional relationships between ATM and the MRN complex, which might be related to the very early events in the DSB response.
120. Joenje, H. & Patel, K. J. The emerging genetic and molecular basis of Fanconi anaemia. Nature Rev. Genet. 2, 446-457 (2001).
121. Nakanishi, K. et al. Interaction of FANCD2 and NBS1 in the DNA damage response. Nature Cell Biol. 4, 913-920 (2002). References 121 and 122 show the functional interaction between FANCD2 and NBS1 in the interstrand crosslink repair pathway, adding another thread to the damage-response network and drawing an additional line connecting different chromosomal instability syndromes.
122. Pichierri, P., Averbeck, D. & Rosselli, F. DNA cross-link-dependent RAD50/MRE11/NBS1 subnuclear assembly requires the Fanconi anemia C protein. Hum. Mol. Genet. 11, 2531-2546 (2002).
123. Beamish, H. et al. Functional link between BLM defective in Bloom's syndrome and the ataxia-telangiectasia-mutated protein, ATM. J. Biol. Chem. 277, 30515-30523 (2002). The finding that the Bloom's syndrome gene product, BLM, is an ATM target further intensifies the cross-talk between the chromosomal breakage syndromes.
124. Franchitto, A. & Pichierri, P. Bloom's syndrome protein is required for correct relocalization of RAD50/MRE11/NBS1 complex after replication fork arrest. J. Cell Biol. 157, 19-30 (2002).
125. Tibbetts, R. S. et al. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13, 152-157 (1999).
126. Zou, L., Cortez, D. & Elledge, S. J. Regulation of ATR substrate selection by Rad17-dependent loading of Rad9 complexes onto chromatin. Genes Dev. 16, 198-208 (2002).
127. Hammond, E. M., Denko, N. C. Dorie, M. J. Abraham, R. T. & Giaccia, A. J. Hypoxia links ATR and p53 through replication arrest. Mol. Cell. Biol. 22, 1834-1843 (2002).
128. Heffernan, T. P. et al. An ATR- and Chk1-dependent S checkpoint inhibits replicon initiation following UVC-induced DNA damage. Mol. Cell. Biol. 22, 8552-8561 (2002).
129. Tibbetts, R. S. et al. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 14, 2989-3002 (2000).
130. Unsal-Kacmaz, K., Makhov, A. M., Griffith, J. D. & Sancar, A. Preferential binding of ATR protein to UV-damaged DNA. Proc. Natl Acad. Sci, USA 99, 6673-6678 (2002).
131. Zhao, H. & Piwnica-Worms, H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol. Cell. Biol. 21, 4129-4139 (2001).
132. Guo, Z., Kumagai, A., Wang, S. X. & Dunphy, W. G. Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts. Genes Dev. 14, 2745-2756 (2000).
133. Lopez-Girona, A. et al. Serine-345 is required for Rad3-dependent phosphorylation and function of checkpoint kinase Chk1 in fission yeast. Proc. Natl Acad. Sci. USA 98, 11289-11294 (2001).
134. Nghiem, P., Park, P. K., Kim, Y. S., Desai, B. N. & Schreiber, S. L. ATR is not required for p53 activation but synergizes with p53 in the replication checkpoint. J. Biol. Chem. 277, 4428-4434 (2002).
135. Weiss, R. S., Matsuoka, S., Elledge, S. J. & Leder, P. Hus1 acts upstream of chk1 in a mammalian DNA damage response pathway. Curr. Biol. 12, 73-77 (2002).
136. Hekmat-Nejad, M., You, Z., Yee, M. C., Newport, J. W. & Cimprich, K. A. Xenopus ATR is a replication-dependent chromatin-binding protein required for the DNA replication checkpoint. Curr. Biol. 10, 1565-1573 (2000).
137. de Klein, A. et al. Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice. Curr. Biol. 10, 479-482 (2000).
138. Brown, E. J. & Baltimore, D. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 14, 397-402 (2000).
139. Cortez, D., Guntuku, S., Qin, J. & Elledge, S. J. ATR and ATRIP: partners in checkpoint signaling. Science 294, 1713-1715 (2001). The discovery of ATRIP - an ATR-associated protein that is essential for its stability and activity - was important for understanding how ATR is set in motion following DNA damage.
140. Lupardus, P. J., Byun, T., Yee, M. C., Hekmat-Nejad, M. & Cimprich, K. A. A requirement for replication in activation of the ATR-dependent DNA damage checkpoint. Genes Dev. 16, 2327-2332 (2002).
141. Casper, A. M., Nghiem, P., Arlt, M. F. & Glover, T. W. ATR regulates fragile site stability. Cell 111, 779-789 (2002). ATR - but not ATM - was found to be important for preventing the expression of chromosomal fragile sites in the face of replicative stress. This draws another important distinction between ATM and ATR and points out that ATR is involved in the checkpoint associated with DNA replication rather than with DNA damage.
142. Edwards, R. J., Bentley, N. J. & Carr, A. M. A Rad3-Rad25 complex responds to DNA damage independently of other checkpoint proteins. Nature Cell Biol. 1, 393-398 (1999).
143. Rouse, J. & Jackson, S. P. LCD1: an essential gene involved in checkpoint control and regulation of the MEC1 signalling pathway in Saccharomyces cerevisiae. EMBO J. 19, 5801-5812 (2000).
144. Paciotti, V., Clerici, M., Lucchini, G. & Longhese, M. P. The checkpoint protein Ddc2, functionally related to S. pombe Rad26, interacts with Mec1 and is regulated by Mec1-dependent phosphorylation in budding yeast. Genes Dev. 14, 2045-2059 (2000).
145. Kondo, T., Wakayama, T., Naiki, T., Matsumoto, K. & Sugimoto, K. Recruitment of Mec1 and Ddc1 checkpoint proteins to double-strand breaks through distinct mechanisms. Science 294, 867-870 (2001).
146. Wakayama, T., Kondo, T., Ando, S., Matsumoto, K. & Sugimoto, K. Pie1, a protein interacting with Mec1, controls cell growth and checkpoint responses in Saccharomyces cerevisiae. Mol. Cell. Biol. 21, 755-764 (2001).
147. Rouse, J. & Jackson, S. P. Lcd1p recruits Mec1p to DNA lesions in vitro and in vivo. Mol. Cell 9, 857-869 (2002).
148. Maquat, L. E. & Carmichael, G. G. Quality control of mRNA function. Cell 104, 173-176 (2001).
149. Yamashita, A., Ohnishi, T., Kashima, I., Taya, Y. & Ohno, S. Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the regulation of nonsense-mediated mRNA decay. Genes Dev. 15, 2215-2228 (2001).
150. Denning, G., Jamieson, L., Maquat, L. E., Thompson, E. A. & Fields, A. P. Cloning of a novel phosphatidylinositol kinase-related kinase: characterization of the human SMG-1 RNA surveillance protein. J. Biol. Chem. 276, 22709-22714 (2001).
151. Smith, G. C. & Jackson, S. P. The DNA-dependent protein kinase. Genes Dev. 13, 916-934 (1999).
152. DeFazio, L. G., Stansel, R. M., Griffith, J. D. & Chu, G. Synapsis of DNA ends by DNA-dependent protein kinase. EMBO J. 21, 3192-3200 (2002).
153. Chan, D. W. et al. Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks. Genes Dev. 16, 2333-2338 (2002). Work described in references 153 and 154 shows, for the first time, that DNA-PK activation by DNA damage involves autophosphorylation.
154. Douglas. P. et al. Identification of in vitro and in vivo phosphorylation sites in the catalytic subunit of the DNA-dependent protein kinase. Biochem. J. 368, 243-251 (2002).
155. Yannone, S. M. et al. Werner syndrome protein is regulated and phosphorylated by DNA-dependent protein kinase. J. Biol. Chem. 276, 38242-38248 (2001).
156. Karmakar, P. et al. Werner protein is a target of DNA-dependent protein kinase in vivo and in vitro, and its cetalytic activities are regulated by phosphorylation. J. Biol. Chem. 271, 18291-18302 (2002).
157. Ma, Y., Pannicke, U., Schwarz, K. & Lieber, M. R. Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 108, 781-794 (2002). Here, an important DNA-PK substrate was identified after a long search for physiological substrates of this central player in DSB repair. It is the Artemis protein, which is involved in processing the hairpin structures at the site of DSBs formed during V(D)J recombination.
158. Moshous, D. et al. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105, 177-186 (2001).
159. Khanna, K. K. Cancer risk and the ATM gene: a continuing debate. J. Natl Cancer Inst. 92, 795-802 (2000).
160. Stankovic, T. et al. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am. J. Hum. Genet. 62, 334-345 (1998).
161. Gatti, R. A., Tward, A. & Concannon, P. Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations. Mol. Genet. Metab. 68, 419-423 (1999). A model was suggested to reconcile the apparently conflicting data on cancer predisposition of A-T carriers. The model attributes different degrees of cancer predisposition to different heterozygous ATM mutations. Recent results seem to substantiate this model.
162. Scott, S. P. et al. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer. Proc. Natl Acad. Sci USA 99, 925-930 (2002).
163. Dork, T. et al. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res. 61, 7608-7615 (2001).
164. Spring, K. et al. Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer. Nature Genet. 32, 185-190 (2002). This work provided strong support for the model associating different ATM mutations with different degrees of cancer predisposition in heterozygotes.
165. Spring, K. et al. Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype. Cancer Res. 61, 4561-4568 (2001).
166. Stankovic, T. et al. ATM mutations in sporadic lymphoid tumours. Leuk. Lymph. 43, 1563-1571 (2002).
167. D'Andrea, A. D. & Grompe, M. The Fanconi anaemia/BRCA pathway. Nature Rev. Cancer 3, 23-34 (2003).
168. Howlett, N. G. et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297, 606-609 (2002).
169. Gellert, M. V(D)J recombination: rag proteins, repair factors, and regulation. Annu. Rev. Biochem. 71, 101-132 (2002).
170. Pellegrini, L. et al. Insights into DNA recombination from the structure of a RAD51-BRCA2 complex. Nature 420, 287-293 (2002).
171. Yang, H. et al. BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science 297, 1837-1848 (2002).
172. Tauchi, H. et al. Nbs1 is essential for DNA repair by homologous recombination in higher vertebrate cells. Nature 420, 93-98 (2002).
173. Kobayashi, J. et al. NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT domain. Curr. Biol. 12, 1845-1851 (2002).